You can buy or sell Sunesis and other stocks, options, and ETFs commission-free!
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. The listed name for SNSS is Sunesis Pharmaceuticals, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
Available Nov 16, After Hours